Coronary Stent Market, By Product Type (Drug-Eluting Stent, Bare-Metal Stent, and Bioresorbable Vascular Stent), By Material Type (Metallic, Cobalt Chromium (CoCr), Platinum Chromium (Pt-Cr), Stainless Steel, Nickel Titanium, and Others), By End-User (Hospitals, Cardiac Center, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2029

Report Code: PMI145019 | Publish Date: May 2022 | No. of Pages: 168

Global Coronary Stent Market By Overview

Introduction:

A coronary stent is a tube-shaped device that supplies blood to the heart and is placed in the coronary arteries and is used for the treatment of coronary heart disease.  Increasing geriatric population and their vulnerability towards various diseases are creating the need for medical aids such as coronary stents which in turn drives growth of the global market. Growing cases of cardiovascular diseases is also expected to boost growth of the global market over the forecast period. Coronary angioplasty and stent placement: It is also known as percutaneous coronary intervention (PCI). This procedure is recommended to open the clogged coronary arteries. PCI is recommended especially if patients have chest discomfort due to reduced blood flow and not responding to medication and lifestyle changes The global coronary stent market accounted for US$ 7475 million in 2019 and is estimated to be US$ 11,158.29 million by 2030 and is anticipated to register a CAGR of 6.9%.

Global Coronary Stent Market By Dynamics

Technological Advancement

Technological advancements in the global coronary stents market, such as enhanced workflow, error reduction, and additional capabilities along with improved accuracy, are also fuelling growth of the global market. Nevertheless, key players in the market are making huge investment to develop next generation stents such as bioresorbable stents and drug filled stents which is creating lucrative growth opportunities for the global market.

Rise in number of CVDs

The alarming rise in the number of CVDs, especially vascular diseases, has become the primary growth driver for the global coronary stents market. Changing lifestyles that are characterized by high stress levels, smoking, alcohol consumption, and poor choice of food habits have collectively led to questionable heart health among people globally. As this problem aggravates, the coronary stents market is projected to witness steady growth during the forecast period

Global Coronary Stent Market By Segmentation

 

Source: Prophecy Market Insights |Disclaimer: Data is only a representation. Actual data may vary in the final report.

 

The global coronary stent market report segments the market on the basis of product type, material type, end user, and region.

On the basis of product, the global coronary stent market is segmented into Drug-Eluting Stent, Bare-Metal Stent, and Bioresorbable Vascular Stent. Based on material type, the target market is segmented into Metallic, Cobalt Chromium (CoCr), Platinum Chromium (Pt-Cr), Stainless Steel, Nickel Titanium, and Others. On the basis of end-user, the target market is segmented into Hospitals, Cardiac Center, and Others.

Regional Insights:

On region the global coronary stent market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the market, accounting for a 40% share of the global coronary stents market in 2018. Although the region is expected to retain its dominance during the forecast period, it is likely to grow at a lower CAGR than other regions.

Attribute

Details

Base year for estimation

2020

Forecast period

2020 – 2029

Market representation

Revenue in USD Million & CAGR from 2020 – 2029

Market Segmentation

By Product- Drug-Eluting Stent, Bare-Metal Stent, and Bioresorbable Vascular Stent

By Material– Metallic, Cobalt Chromium (CoCr), Platinum Chromium (Pt-Cr), Stainless Steel, Nickel Titanium, and Others

By End-User– Hospitals, Cardiac Center, and Others

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, The global coronary stent market report segments the market on the basis of product type, material type, end user, and region.

 

Global coronary stent market, By Region:

      • North America
          • U.S.
          • Canada
      • Europe
          • Germany
          • UK
          • France
          • Russia
          • Italy
          • Rest of Europe
      • Asia Pacific
          • China
          • India
          • Japan
          • South Korea
          • Rest of Asia Pacific
      • Latin America
          • Brazil
          • Mexico
          • Rest of Latin America
      • Middle East & Africa
          • GCC
          • Israel
  • South Africa
          • Rest of Middle East & Africa

Global Coronary Stent Market By Key Players

The key players operating in the global coronary stent market includes Biotronik SE & Co. KG, Braun Melsungen AG, Terumo Corporation, Medtronic plc, MicroPort Scientific Corporation, Meril Life Sciences Pvt. Ltd., Abbott Laboratories, Boston Scientific Corporation, STENTYS SA, Biosensors International Group, Ltd.

Global Coronary Stent Market By Company Profile

  • STENTYS SA
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Biotronik SE & Co. KG
  • Braun Melsungen AG
  • Terumo Corporation
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Meril Life Sciences Pvt. Ltd.
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Biosensors International Group, Ltd.

 “*” marked represents similar segmentation in other categories in the respective section

Global Coronary Stent Market By Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Study Scope
    • Years Considered for the study
    • Assumptions
    • Abbreviations
  2. Research Methodology
    • Research data
    • Primary Data
      • Primary Interviews
      • Primary Breakdown
      • Key data from Primary Sources
      • Key Thickness Insights
    • Secondary Data
      • Major Secondary Sources
      • Secondary Sources
    • Market Estimation
    • Top-Down Approach
      • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
    • Bottom-Up Approach
      • Approach for estimating market share by Bottom-up Analysis (Demand Side)
    • Market Breakdown and Data Triangulation
    • Research Assumptions
    • PORTER’s
    • Investment Outlook
  3. Market Purview
  4. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Overview
    • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
    • Y-o-Y Growth Analysis (%), 2020 – 2030
    • Regional Trends
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  5. Regional Analysis
    • Regional Revenue Analysis
    • Regional By segment Analysis
    • Reasons for regional growth
    • Key Player of particular region
    • Countries Include in the report:
      • North America (U.S., Canada)
      • Europe (UK, France, Germany, Russia, Italy, Rest of Europe)
      • Asia Pacific (India, Japan, South Korea, China, Rest of Asia Pacific)
      • Latin America (Brazil, Mexico, Rest of Latin America)
      • Middle East & Africa (GCC, Israel, South Africa, Rest of Middle East)
  1. Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis
    • Competitive Overview
    • Competitive Benchmarking
    • Market Share Analysis
    • Key Developments In The Global Global Coronary Stent Market Market
    • Key Developments: Mergers & Acquisitions
    • Key Developments: Collaboration
    • Key Developments: Contracts & Agreements
    • Key Developments: Expansion
    • Key Developments: Product Developments
  2. Company Profiles

 

  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
  • SWOT Analysis
    • STENTYS SA

      • Company Overview

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Business Strategies

    • Biotronik SE & Co. KG

    • Braun Melsungen AG

    • Terumo Corporation

    • Medtronic plc

    • MicroPort Scientific Corporation

    • Meril Life Sciences Pvt. Ltd.

    • Abbott Laboratories

    • Boston Scientific Corporation

    • Biosensors International Group, Ltd.

  1. The Last Word
    • Future Impact
    • About Us
    • Contact

 

FAQs

The global coronary stent market report segments the market on the basis of product type, material type, end user, and region

The alarming rise in the number of CVDs, especially vascular diseases, has become the primary growth driver for the global coronary stents market.

North America dominated the market, accounting for a 40% share of the global coronary stents market in 2018. Although the region is expected to retain its dominance during the forecast period, it is likely to grow at a lower CAGR than other regions.

The key players operating in the global coronary stent market includes Biotronik SE & Co. KG, Braun Melsungen AG, Terumo Corporation, Medtronic plc, MicroPort Scientific Corporation, Meril Life Sciences Pvt. Ltd., Abbott Laboratories, Boston Scientific Corporation, STENTYS SA, Biosensors International Group, Ltd.